Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of ASP5094 after multiple intravenous doses in rheumatoid arthritis patients on methotrexate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASP5094

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Rheumatoid Arthritis (RA) | Phase 1 | Status: COMPLETED